Related Experiment Video
Updated: Jul 11, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Fatal consequences of climbing a ladder under apixaban and drunken
Claudia Stöllberger1, Josef Finsterer1
1Krankenanstalt Rudolfstiftung, Wien, Austria.
Background:
Apixaban, a factor-Xa-inhibitor, is one of the non-vitamin-K-antagonist oral anticoagulants (NOACs) which are increasingly used in atrial fibrillation (AF). In real life even patients with contraindications to vitamin K antagonists (VKAs) receive NOAC because NOAC are considered as "safer" than VKAs.
Case Description:
In a 61-years-old man with hypertension, heart failure and paroxysmal AF apixaban was started. Despite advices from his physicians, he continued alcohol abuse and suffered from recurrent falls. After 9 months he fell from a ladder and suffered from extensive subarachnoidal and intraparenchymal hemorrhages, subdural hematoma, brain edema with midline shift and a left-sided skull fracture. Because of the inability to reverse the anticoagulant therapy, no neurosurgical intervention was carried out and the patient died without regaining consciousness.
Conclusions:
Patients with recurrent falls or chronic alcohol abuse should not be considered as candidates for NOACs. If anticoagulation is deemed necessary, VKA with its potential for prompt reversibility should be favored.
Related Concept Videos
Physical Properties of Amines
Prevention of Further Absorption of Poison
Drug Toxicity: Overview
Drug toxicity: Drug–Drug Interaction
Pharmaceutical Poisoning: Potential Scenarios
Cardiac Catheterization I: Pre-Procedure Overview

